Jan. 3, 2025 — Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug ... 'Dancing the Blues Away' Seen in Brain ...

Jan. 3, 2025 — Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug ... 'Dancing the Blues Away' Seen in Brain ...

Diets rich in antioxidants and omega-3 fatty acids may benefit people with Parkinson’s. Eating or limiting other foods may also help, but research is ongoing. Share on Pinterest Nadine Greeff ...

Parkinson's disease is characterized by a collection of uniquely distinguishing symptoms that affect movement and a number of other aspects of daily life. These include, but are not limited to, ...

Researchers have uncovered a new understanding of levodopa-induced dyskinesia, a common side effect in Parkinson’s patients, revealing that the motor cortex disconnects rather than directly causing ...

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients: uncontrollable movements that develop after years of ...

Parkinson’s disease (PD) may lead to an increased risk of developing severe illness and a more complicated recovery from a COVID-19 infection. Generally, respiratory infections such as pneumonia can ...

The temporomandibular joint (TMJ) is the hinge-like bone that connects your jaw and your skull. You can feel it moving by pressing your index fingers to your cheeks and opening and closing your mouth.

Symptoms of Parkinson's disease typically appear gradually and worsen over time. Symptoms and the speed of progression vary from person to person. Early detection of Parkinson's can help people ...

Half a million people in the U.S. have been diagnosed with Parkinson's disease. Parkinson's disease is known for the tremors that it causes, but about half of patients experiencing the disease ...

Nigel was living with vascular dementia, which can present with symptoms similar to Parkinson’s disease, a progressive neurological disorder characterized by motor symptoms such as tremors ...

UCB’s Novartis-partnered investigational small molecule has failed to improve symptoms of Parkinson’s disease in a phase 2a trial. The oral asset—dubbed minzasolmin—missed the study’s ...